Santé Botanica - The Clean Clone Company™ Revenue and Competitors
Estimated Revenue & Valuation
- Santé Botanica - The Clean Clone Company™'s estimated annual revenue is currently $2.3M per year.
- Santé Botanica - The Clean Clone Company™'s estimated revenue per employee is $155,000
Employee Data
- Santé Botanica - The Clean Clone Company™ has 15 Employees.
- Santé Botanica - The Clean Clone Company™ grew their employee count by 15% last year.
Santé Botanica - The Clean Clone Company™'s People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Partner and Co-Founder at Sante Botanica | Reveal Email/Phone |
3 | Partner & Co-Founder | Reveal Email/Phone |
4 | Tissue Culture Specialist | Reveal Email/Phone |
Santé Botanica - The Clean Clone Company™ Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Santé Botanica - The Clean Clone Company™?
Santé Botanica - The Clean Clone Company™ - is a biotechnology company specializing in cannabis tissue culture related services and pathogen-free clone production. We are currently serving California's legal cannabis market and are expanding into new markets. Our services include large-scale production of pathogen-free clones, strain clean-up services, cryogenic preservation and genetic sourcing.
keywords:N/AN/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 15 | 0% | N/A |
#2 | $2.9M | 19 | -37% | N/A |
#3 | $7.1M | 33 | -8% | N/A |
#4 | $7.3M | 36 | 9% | N/A |
#5 | $8.8M | 38 | -27% | N/A |